Prevalence of alcohol and other psychoactive substances in injured drivers: Comparison between Belgium and the Netherlands

Forensic Science International

Volumn 220, Issue 1-3, 2012, Pages 224-231

  Legrand, Sara Ann ^a   Houwing, Sjoerd ^b   Hagenzieker, Marjan ^b   Verstraete, Alain G ^a  

^a GHENT UNIVERSITY   (Belgium)

^b SWOV INSTITUTE FOR ROAD SAFETY RESEARCH   (Netherlands)

Author keywords

Alcohol; Belgium; Injured drivers; Prevalence; Psychoactive substances; The Netherlands

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; ILLICIT DRUG; NARCOTIC ANALGESIC AGENT;

ADULT; ALCOHOL ABUSE; ARTICLE; BELGIUM; BLOOD SAMPLING; CAR DRIVER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUNKEN DRIVING; FEMALE; FORENSIC IDENTIFICATION; HUMAN; INTERMETHOD COMPARISON; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SUBSTANCE ABUSE; TOXICITY TESTING; TRAFFIC ACCIDENT;

EID: 84862673727     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2012.03.006     Document Type: Article

References (40)

1. Raes E., Van den Neste T., Verstraete A.G. Drug Use, Impaired Driving and Traffic Accidents 2008, European Monitoring Center for Drugs and Drug Addiction, Portugal.
2. Meulemans A., Hooft P., Van Camp L., De Vrieze N., Buylaert W., Verstraete A., Vansnick M. Belgian Toxicology and Trauma Study (BTTS). A Study on Alcohol, Medication and Illicit Drugs in Drivers-victims of Road Traffic Accidents 1998, Belgian Society of Emergency and Disaster Medicine, Toxicological Society of Belgium and Luxemburg, Belgian Road Safety Institute, Leuven.
3. Schepens P.J., Pauwels A., Van Damme P., Musuku A., Beaucourt L.M., Selala I. Drugs of abuse and alcohol in weekend drivers involved in car crashes in Belgium. Ann. Emerg. Med. 1998, 31:633-637.
4. Verstraete A.G. Results of the Belgian Toxicology and Trauma study (BTTS): prevalence of drugs in blood and urine of injured drivers. Blutalkohol 2000, 37:44-52.
5. Assum T., Mathijssen M.P.M., Houwing S. The Prevalence of Drug Driving and Relative Risk Estimations. A Study Conducred in The Netherlands, Norway and United Kingdom 2005, Australian Road Safety Board, Vienna.
6. Smink B.E., Ruiter B., Lusthof K.J., de Gier J.J., Uges D.R.A., Egberts A.C.G. Drug use and the severity of a traffic accident. Accid. Anal. Prev. 2005, 37:427-433.
7. Goessaert A., Pil K., Veramme J., Verstraete A. Analytical evaluation of a rapid on-site oral fluid drug test. Anal. Bioanal. Chem. 2010, 396:2461-2468.
8. Association for the advancement of Automotive Medicine (AAAM), International Injury Scaling (AIS) 2005 - update 2008, Barrington, 2008.
9. Goessaert A., Pil K., Veramme J., Verstraete A. Analytical evaluation of a rapid on-site oral fluid drug test. Anal. Bioanal. Chem. 2010, 396:2461-2468.
10. Blencowe T., Pehrsson A., Lillsunde P., Vimpari K., Houwing S., Smink B., Mathijsen R., Van der Linden T., Legrand S.-A., Pil K., Verstraete A.G. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Sci. Int. 2011, 20:173-179.
11. Wilson E.B. Probable inference, the law of succession, and statistical inference. J. Am. Stat. Assoc. 1927, 22:209-212.
12. C. Isalberti, T. Van der Linden, S.-A. Legrand, A.G. Verstraete, I. Bernhoft, T. Hels, M. Olesen, S. Houwing, M. Hagenzieker, R. Mathijssen, DRUID-Deliverable 2.2.5: Prevalence of alcohol and other psychoactive substances in injured and killed drivers, Country report Belgium, 2011, pp. 180-221.
13. Stichting Wetenschappelijk Onderzoek Verkeersveiligheid, SWOV-Factsheet: Verkeersslachtoffers in Nederland, Leidschendam, 2010.
14. Belgische Instituut voor Verkeersveiligheid, Verkeersveiligheidsbarometer 2010, Brussel, 2011.
15. European Commission, EU Transport in figures, Luxembourg, 2011.
16. Longo C.M., Hunter C.E., Lokan R.J., White J.M., White M.A. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part I: the prevalence of drug use in drivers, and characteristics of the drug-positive group. Accid. Anal. Prev. 2000, 32:613-622.
17. Longo C.M., Hunter C.E., Lokan R.J., White J.M., Williamson M. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part II: the relationship between drug prevalence and drug concentration, and driver culpability. Accid. Anal. Prev. 2000, 32:623-632.
18. Ricci G., Majori S., Mantovani W., Zappaterra A., Rocca G., Buonocore F. Prevalence of alcohol and drugs in urine of patients involved in road accidents. J. Prev. Med. Hyg. 2008, 49:89-95.
19. Palmentier J.P.F.P., Warren R., Gorczynski L.Y. Alcohol and drugs in suspected impaired drivers in Ontario from 2001 to 2005. J. Forensic Legal Med. 2009, 16:444-448.
20. Bogstrand S.T., Normann P.T., Rossow I., Larsen M., Mørland J., Ekeberg Ø. Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department. Drug Alcohol Depend. 2011, 11:132-138.
21. K. Veisten, S. Houwing, R. Matthijsen, Cost-Benefit analysis of drug driving enforcement by the police, DRUID Project (Driving under the influence of alcohol, drugs and medicines), 2010. Available at: . http://www.druid-project.eu/.
22. Belgisch Instituut voor de Verkeersveiligheid, Rijden onder invloed van alcohol-Resultaten van de gedragsmeting 2009, Brussel, 2010.
23. Belgisch Instituut voor de Verkeersveiligheid, Attitudemeting verkeersveiligheid 2009, Evoluties sinds 2003-2006, Brussel, 2010.
24. Stichting Farmaceutische Kengetallen, Benzo's grotendeels voor eigen rekening, Pharmaceutisch Weekblad, 144(9) (2009).
25. Stichting Farmaceutische Kengetallen, Benzogebruik met een zesde teruggelopen, Pharmaceutisch Weekblad, 144(38) (2009).
26. Bakker A., Van Balkom A., Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr. Scand. 2002, 106:163-167.
27. Kwaliteitsinstituut voor de Gezondheidszorg CBO, Richtlijn voor de diagnostiek behandeling en begeleiding van volwassen patiënten met een angststoornis, Alphen aan den Rijn, 2009.
28. Stichting Farmaceutische Kengetallen, Kosten antidepressiva flink gedaald, Pharmaceutisch Weekblad, 144(13) (2009).
29. Stichting Farmaceutische Kengetallen, Kosten antidepressiva gehalveerd, Pharmaceutisch Weekblad, 145(5) (2010).
30. Pelfrene E., Vlerick P., Moreau M., Mak R.P., Kornitzer M., De Backer G. Use of benzodiazepine drug and perceived job stress in a cohort of working men and women in Belgium. results from the BELSTRESS-study. Soc. Sci. Med. 2004, 59:433-442.
31. Groenewegen P.P., Leufkens H.G., Spreeuwenberg P.D., Worm W. Neighbourhood characteristics and use of benzodiazepines in the Netherlands. Soc. Sci. Med. 1999, 48:1701-1711.
32. Van Rijswijk E., Van de Lisdonk H.E., Zitman G.F. Who uses over the-counter psychotropics? Characteristics, functioning and (mental)health profile. Gen. Hosp. Psychiatry 2000, 22:234-241.
33. Van der J., Heyden Gezondheidsenquête 2008. Gebruik van Geneesmiddelen 2009, Wetenschappelijk Instituut Volksgezondheid, Brussel.
34. Borrenbergen K. Campagne Slaap- en Kalmeermiddelen Federale Overheidsdienst Volksgezonheid 2011, veiligheid van de voedselketen en leefmilieu, Brussel.
35. Rijksinstituut voor ziekte- en invaliditeitsverzekering, Dienst voor geneeskundige verzorging, Wetenschappelijke raad, Farmaceutische kengetallen van de Farmaceutische Verstrekkingen in de Ambulante Praktijk, Brussel, 2008.
36. R.J. MacCoun, Paper: What can we learn from the Dutch Cannabis Coffeeshop System? 2011. Available at: . http://papers.ssrn.com/sol3/papers.cfm%3Fabstract_id=1862363.
37. ter Boght T., Schmid H., Gabhainn S.N., Fotiou A., Vollebergh W. Economic and cultural correlates of cannabis use among mid-adolescents in 31 countries. Addiction 2006, 101:242-251.
38. Kuntsche E., Simons-Morton B., Fotiou A., ter Boght T., Kokkevi A. Decrease in adolescent cannabis use from 2002 to 2006 and links to evenings out with friends in 31 European and North America countries and regions. Arch. Pediatr. Adolesc. Med. 2009, 163:119-125.
39. Degenhardt L., Wai-Tat C., Sampson N., Kessler R.C., Anthony J.C., Angermeyer M., Bruffaerts R., de Girolamo G., Gureje O., Huang Y., Karam A., Kostyuchenko S., Lepine J.P., Mora M.E.M., Neumark Y., Ormel J.H., Pinto-Meza A., Posada-Villa J., Stein D.J., Takeshima T., Wells J.E. Toward a global view of alcohol, tabacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008, 5:1053-1066.
40. Roomer A., Akouele T. Alcohol Drugs & Verkeer. Een onderzoek onder bezoekers van coffeeshops en grootschalige discotheken in de regio Nijmegen (Nederland)-Kleve (Duitsland) 2006, Stadsregio Arnhem Nijmegen.